Short-term effect of 0.01% atropine sulphate eye gel on myopia progression in children
Author:
Corresponding Author:

Xiang-Hua Xiao. Research for Ophthalmology Diseases of Shaanxi Province, Xi’an First Hospital; Shaanxi Key Laboratory of Ophthalmology, Shaanxi institute of Ophthalmology, Xi’an 710002, Shaanxi Province, China. xianghuaxiao@yeah.net. Jun-Tian Liu. Department of Pharmacology, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center, Xi’an 710061, Shaanxi Province, China. ljt@mail.xjtu.edu.cn

Affiliation:

Clc Number:

Fund Project:

Supported by Shaanxi Province Social Development and Technology of Research Project (No. 2020SF-274; No.2014K11-03-07-05); Xi’an Science and Technology Project (No.20YXYJ0008-6).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    AIM: To investigate the effect of 0.01% atropine sulphate eye gel on myopia progression and axial elongation in a 6-month treatment in children. METHODS: Totally 185 children aged 6-12y with binocular myopia of 3.0 D or less in both eyes were enrolled in this prospective cohort study. The atropine group (n=125) received one drop of 0.01% atropine sulphate eye gel in each eye before bedtime daily. The control group included 60 matched children without drug intervention during the same period. The spherical equivalent and axial length was recorded at baseline and the sixth month of treatment. The efficacy was evaluated by the change of the spherical equivalent and axial length. Adverse events were also recorded. RESULTS: The average spherical equivalent and axial length at baseline were not statistically significant between the atropine group (-1.64±0.80 D, 24.13±0.76 mm) and the control group (-1.59±0.94 D, 24.06±0.77 mm, P>0.05). After 6mo, there was significantly difference in the spherical equivalent progression between the atropine and the control group (-0.27±0.33 vs -0.60±0.35 D, P<0.001), with a relative reduction of 55.0% in myopia progression. The increase in axial elongation in the atropine group was significantly less than control group (0.19±0.14 vs 0.26±0.14 mm, P<0.001), with a relative reduction of 26.9% in axial length. The 84.4% and 38.4% of the eyes progressed by less than 0.50 D and remained stable in the atropine group, compared with 51.7% and 4.2% in the control group. No adverse events were observed. CONCLUSION: Atropine sulphate eye gel 0.01% can slow down myopia progression and axial elongation in children with a 6-month treatment.

    Reference
    Related
    Cited by
Get Citation

Shi-Yin Pan, Yang-Zheng Wang, Jun Li, et al. Short-term effect of 0.01% atropine sulphate eye gel on myopia progression in children. Int J Ophthalmol, 2022,15(7):1122-1127

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:July 08,2021
  • Revised:September 09,2021
  • Adopted:
  • Online: June 30,2022
  • Published: